The NECAP1 gene is associated with a rare neurological condition known as Early Infantile Epileptic Encephalopathy Type 21 (EIEE21). This condition is characterized by severe seizures that begin in the first few months of life, along with developmental delays and other possible neurological abnormalities. The NECAP1 gene plays a crucial role in brain development and function, and mutations in this gene can lead to the symptoms observed in EIEE21.
To diagnose this condition, a genetic test targeting the NECAP1 gene can be performed. This test is crucial for confirming the diagnosis, understanding the condition's progression, and aiding in the management and treatment planning for affected individuals. It involves analyzing the DNA to identify mutations in the NECAP1 gene that are known to cause EIEE21.
In the United Arab Emirates, this specific genetic test can be conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the NECAP1 gene test for Early Infantile Epileptic Encephalopathy Type 21 is 4400 AED. This test is significant for families with a history of the condition or for infants showing symptoms associated with EIEE21, as it provides a definitive diagnosis and can guide further medical and therapeutic interventions.
The DOCK7 gene is associated with early infantile epileptic encephalopathy type 23 (EIEE23), a severe neurological disorder that typically manifests in the early stages of infancy. This condition is characterized by frequent seizures that are resistant to treatment, along with developmental delays and other potential neurological issues. The DOCK7 gene plays a crucial role in brain development and function, and mutations in this gene can disrupt normal neurological processes, leading to the symptoms observed in EIEE23.
To diagnose this condition accurately, genetic testing for mutations in the DOCK7 gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the DOCK7 gene that are associated with early infantile epileptic encephalopathy type 23. This test is a critical tool for clinicians in diagnosing the condition, allowing for a better understanding of the prognosis and informing treatment strategies.
The cost of the DOCK7 gene test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and the subsequent analysis of the DOCK7 gene for any mutations. The results from this test can provide invaluable insights for families and healthcare providers, guiding them towards appropriate care and support for affected individuals.
Overall, the DOCK7 gene test offered by DNA Labs UAE is a specialized diagnostic tool that plays a pivotal role in identifying early infantile epileptic encephalopathy type 23, facilitating early intervention and tailored management plans for patients with this challenging condition.
The HCN1 gene plays a crucial role in the development and function of the brain. Mutations in this gene have been associated with early infantile epileptic encephalopathy type 24 (EIEE24), a severe form of epilepsy that manifests in the first few months of life. This condition is characterized by frequent seizures, developmental delays, and other neurological issues. Given the serious nature of EIEE24, early diagnosis is essential for managing symptoms and improving the quality of life for affected individuals.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the HCN1 gene. This test is a vital tool for diagnosing EIEE24, allowing for targeted treatment plans and genetic counseling for families. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the HCN1 gene.
The cost of the HCN1 gene test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test provides invaluable information for the management of EIEE24, potentially leading to better outcomes for affected infants. It is recommended for families with a history of this condition or those whose infants show symptoms suggestive of EIEE24.
The "ADCY5 Gene Dyskinesia Familial with Facial Myokymia Genetic Test" is a specialized diagnostic tool designed to identify mutations in the ADCY5 gene, which are linked to a rare genetic disorder. This condition is characterized by dyskinesia—a disorder resulting in involuntary, erratic muscle movements—and facial myokymia, which involves continuous, rapid twitching of the facial muscles. These symptoms can significantly impact the quality of life, making accurate diagnosis crucial for management and treatment planning.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing, ensuring high accuracy and reliability of results. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. By pinpointing the specific genetic alterations in the ADCY5 gene, this test enables healthcare professionals to confirm a diagnosis of ADCY5-related dyskinesia, facilitating tailored treatment approaches and genetic counseling for affected individuals and their families.
The PDE10A gene dyskinesia limb and orofacial infantile-onset genetic test is a specialized diagnostic tool aimed at identifying mutations in the PDE10A gene, which have been associated with early-onset movement disorders affecting the limbs and orofacial regions. This condition is characterized by involuntary muscle contractions leading to abnormal postures and movements, significantly impacting the quality of life from a very young age. The test is particularly relevant for individuals displaying symptoms of dyskinesia without a clear diagnosis, offering insights that can guide treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the PDE10A gene. The cost of the test is 4400 AED, reflecting the intricate processes and advanced technology employed to achieve accurate and reliable results. By identifying the genetic underpinnings of the disorder, this test not only facilitates a better understanding of the individual's condition but also aids in the exploration of potential genetic counseling for families, providing them with valuable information regarding the inheritance patterns and risks for future offspring.
The PCDH11X Gene Dyslexia Genetic Test is a specialized diagnostic tool designed to identify genetic markers associated with dyslexia, specifically focusing on the PCDH11X gene located on the X chromosome. This gene has been implicated in neurological development and is thought to play a crucial role in the development of dyslexia, a common learning disorder characterized by difficulties in reading despite normal intelligence and adequate instruction.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers individuals and families insights into the genetic underpinnings of dyslexia, potentially aiding in early detection and the implementation of targeted educational strategies and interventions. The test involves collecting a DNA sample, typically through a simple and non-invasive saliva or blood sample, which is then analyzed for specific genetic variations in the PCDH11X gene that are linked to dyslexia.
The cost of the PCDH11X Gene Dyslexia Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the comprehensive analysis of the genetic sample, a detailed report of the findings, and, in some cases, a consultation to discuss the results and their implications. By identifying a genetic predisposition to dyslexia, parents, educators, and healthcare providers can work together to support individuals with dyslexia, tailoring learning approaches to their unique needs and helping them to achieve their full academic potential.
The HSPG2 gene dyssegmental dysplasia Silverman-Handmaker type genetic test is a specialized diagnostic tool designed to identify mutations in the HSPG2 gene, which are responsible for causing dyssegmental dysplasia Silverman-Handmaker type. This rare genetic disorder is characterized by severe skeletal abnormalities that affect the development of the ribs and limbs, leading to significant physical impairments. The condition is inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the HSPG2 gene. This test is crucial for accurate diagnosis and can also be used for carrier testing in individuals with a family history of the condition, as well as for prenatal diagnosis.
The cost of the HSPG2 gene dyssegmental dysplasia Silverman-Handmaker type genetic test at DNA Labs UAE is 4400 AED. While the price may seem steep, the test provides invaluable information for affected individuals and their families, offering insights into the condition and informing decisions regarding management and care. Early and precise diagnosis through genetic testing can significantly impact the quality of life for those with dyssegmental dysplasia Silverman-Handmaker type and assist healthcare providers in developing the most appropriate treatment plans.
The ACTB Gene Dystonia Juvenile-Onset Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ACTB gene that are associated with the early onset of dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. The ACTB gene plays a crucial role in the production of beta-actin, a protein essential for cell structure and integrity, and mutations in this gene can disrupt normal muscle function and lead to dystonia.
This genetic test is particularly important for individuals showing symptoms of dystonia at a young age, as early detection can significantly impact the management and treatment options available. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the ACTB gene that are known to cause juvenile-onset dystonia.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test not only aids in the accurate diagnosis of dystonia but also helps in understanding the genetic predisposition of the condition, enabling families to make informed decisions regarding future family planning. The results from this test can also provide valuable information for personalized treatment plans, improving the quality of life for those affected by this challenging condition.
The SPR Gene Dystonia DOPA-Responsive Autosomal Recessive Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SPR gene that are known to cause DOPA-responsive dystonia. This condition is a rare, inherited neurological disorder characterized by muscle contractions leading to repetitive movements or abnormal postures. These symptoms are notably responsive to treatment with DOPA, a precursor to dopamine, which is a neurotransmitter involved in controlling movement. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the SPR gene, which plays a critical role in dopamine biosynthesis. Identifying these mutations can confirm a diagnosis of DOPA-responsive dystonia, enabling healthcare providers to recommend the most effective treatment strategies. Conducted at DNA Labs UAE, this genetic test is a vital resource for individuals experiencing symptoms of dystonia seeking a definitive diagnosis and tailored treatment plan.
The TIMM8A gene dystonia-deafness syndrome, also known as Mohr-Tranebjaerg syndrome, is a rare genetic disorder characterized by progressive hearing loss, dystonia, visual impairment, and neurological decline. The condition is inherited in an X-linked recessive pattern, affecting primarily males, though female carriers may exhibit some symptoms.
To diagnose this condition, a specific genetic test targeting the TIMM8A gene can be conducted. DNA Labs UAE offers this specialized test, designed to detect mutations in the TIMM8A gene that are responsible for the syndrome. The test is crucial for accurate diagnosis, enabling early intervention and management strategies to alleviate symptoms and improve quality of life for affected individuals.
The cost of the TIMM8A gene dystonia-deafness syndrome genetic test at DNA Labs UAE is 4400 AED. This price includes the genetic analysis and a comprehensive report, which provides detailed insights into the individual's genetic makeup concerning the TIMM8A gene. The test is conducted with a high level of accuracy, using advanced genomic technologies to ensure reliable results. Families with a history of the syndrome or individuals showing symptoms are encouraged to consider this test for a definitive diagnosis and to inform potential treatment paths.
